Nutrition and Trauma - The Influence of Malnutrition in Geriatric Trauma Patients (NCT07582575) | Clinical Trial Compass
CompletedNot Applicable
Nutrition and Trauma - The Influence of Malnutrition in Geriatric Trauma Patients
Germany218 participantsStarted 2024-05-01
Plain-language summary
Due to demographic changes, the geriatric patient population is growing, leading to a higher incidence of osteoporotic fractures associated with multimorbidity and frailty. Up to 60% of elderly patients are at risk of malnutrition, which is associated with a high rate of post-operative complications, prolonged hospitalisation, poorer return to independence and increased mortality.
The NuTra study investigates the prevalence of malnutrition, evaluates screening tools and analyses the impact of protein-rich diets on postoperative outcomes in geriatric trauma. The aim is to develop evidence-based approaches to the prevention and treatment of malnutrition in order to improve the medical outcome and quality of life of geriatric trauma patients and reduce healthcare costs.
Who can participate
Age range
70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Patients aged ≥70 years
* Acute fractures of the proximal humerus, vertebral body, pelvis, acetabulum, proximal femur, or periprosthetic fractures of the lower extremity
* Admission for acute fracture management
* Ability to provide written informed consent
Exclusion criteria:
* Age \<70 years
* Dementia or relevant cognitive impairment precluding informed consent
* Progressive malignancy
* Palliative treatment goals
* Refusal or inability to provide informed consent
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of participants with medical complications during index hospitalization
Timeframe: Day 1 (Baseline, Hospital admission) up to 3 weeks.
2
Number of participants with surgical site infection during index hospitalization
Timeframe: Postoperative day 1 up to 3 weeks postoperative.
3
Functional mobility at discharge
Timeframe: Day 1 (Baseline, Hospital admission) up to 3 weeks.
Trial details
NCT IDNCT07582575
SponsorDepartment of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu